新芝生物
(430685)
| 流通市值：5.07亿 | | | 总市值：10.41亿 |
| 流通股本：4458.44万 | | | 总股本：9151.60万 |
| 报告期 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 154,428,367.12 | 159,618,680.6 | 129,280,366.78 | 172,493,886.89 |
| 应收票据及应收账款 | 7,236,276.98 | 6,554,491.93 | 9,655,351.73 | 9,564,812.46 |
| 其中：应收票据 | 719,833.55 | 162,000 | 504,720.8 | 500,000 |
| 应收账款 | 6,516,443.43 | 6,392,491.93 | 9,150,630.93 | 9,064,812.46 |
| 预付款项 | 4,412,524.08 | 4,567,551.22 | 4,343,584.93 | 4,609,137.25 |
| 其他应收款合计 | 1,102,508.27 | 1,181,498.54 | 1,064,677.27 | 1,129,787.64 |
| 存货 | 49,726,654.89 | 50,568,975.19 | 47,891,201.06 | 54,169,402.42 |
| 其他流动资产 | 2,630,957.49 | 966,827.47 | 1,335,215.05 | 33,261.54 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 426,557,543.14 | 485,042,394.82 | 500,099,224.08 | 500,805,461.91 |
| 非流动资产: | | | | |
| 长期股权投资 | - | - | - | 0 |
| 投资性房地产 | - | - | - | 1,429,896.55 |
| 固定资产 | 43,114,445.37 | 44,682,748.06 | 45,786,568.68 | 44,868,594.46 |
| 在建工程 | 84,037,860.99 | 58,773,560.05 | 22,392,851.47 | 4,125,921.91 |
| 使用权资产 | 4,676,547.16 | 5,316,052 | 6,513,144.52 | 7,397,926.62 |
| 无形资产 | 21,653,229.5 | 21,715,753.1 | 21,892,077.89 | 21,560,887.15 |
| 商誉 | 6,868,485.01 | - | - | - |
| 长期待摊费用 | 1,805,548.75 | 1,686,641.14 | 2,040,719.82 | 2,278,672.56 |
| 递延所得税资产 | 2,216,304.68 | 6,895,187.57 | 6,902,134.06 | 1,907,425.02 |
| 其他非流动资产 | 1,710,835.9 | 1,710,835.9 | 5,616,294.44 | 1,780,693.37 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 166,083,257.36 | 140,780,777.82 | 111,143,790.88 | 85,350,017.64 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 592,640,800.5 | 625,823,172.64 | 611,243,014.96 | 586,155,479.55 |
| 流动负债: | | | | |
| 短期借款 | - | - | - | 0 |
| 应付票据及应付账款 | 25,224,769.53 | 33,750,329.99 | 7,264,545.96 | 7,023,112.65 |
| 应付账款 | 25,224,769.53 | 33,750,329.99 | 7,264,545.96 | 7,023,112.65 |
| 合同负债 | 9,624,938.56 | 10,246,611.27 | 6,060,028.51 | 10,743,341.33 |
| 应付职工薪酬 | 8,897,729.71 | 6,037,939 | 20,570,408.35 | 14,453,683.13 |
| 应交税费 | 1,233,039.75 | 546,783.38 | 4,030,058.69 | 8,827,065.3 |
| 其他应付款合计 | 287,598.21 | 52,517.22 | 50,341.31 | 82,333.3 |
| 一年内到期的非流动负债 | 3,191,342.35 | 3,355,043.68 | 3,686,851.71 | 3,640,225.99 |
| 其他流动负债 | 923,999.21 | 740,332.21 | 823,169.72 | 961,979.11 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 49,383,417.32 | 54,729,556.75 | 42,485,404.25 | 45,731,740.81 |
| 非流动负债: | | | | |
| 长期借款 | - | - | - | 0 |
| 租赁负债 | 756,605.82 | 1,500,472.33 | 2,236,392.69 | 3,194,842.95 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 756,605.82 | 1,500,472.33 | 2,236,392.69 | 3,194,842.95 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 50,140,023.14 | 56,230,029.08 | 44,721,796.94 | 48,926,583.76 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 91,515,941 | 91,515,941 | 91,515,941 | 91,515,941 |
| 资本公积 | 352,285,962.96 | 356,702,211.88 | 356,394,735.77 | 325,395,601.53 |
| 减:库存股 | 28,235,967.38 | 28,235,967.38 | 27,736,004.94 | 26,138,269.43 |
| 盈余公积 | 28,934,321.39 | 28,934,321.39 | 28,934,321.39 | 23,188,363.51 |
| 未分配利润 | 65,916,808.03 | 91,343,101.95 | 88,407,380.75 | 99,499,550.69 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 510,417,066 | 540,259,608.84 | 537,516,373.97 | 513,461,187.3 |
| 少数股东权益 | 32,083,711.36 | 29,333,534.72 | 29,004,844.05 | 23,767,708.49 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 542,500,777.36 | 569,593,143.56 | 566,521,218.02 | 537,228,895.79 |
| 负债和股东权益合计 | 592,640,800.5 | 625,823,172.64 | 611,243,014.96 | 586,155,479.55 |
| 公告日期 | 2024-08-27 | 2024-04-26 | 2024-04-22 | 2023-10-27 |
| 审计意见(境内) | | | 标准无保留意见 | |